PBYI compared with TCMD: revenue, margins and what each company keeps, and the suppliers and customers both name

PBYIPuma Biotechnology, Inc.

Mkt capRevenueRevenue

TCMDTactile Systems Technology Inc

Mkt capRevenueRevenue

Compare

PBYIPuma Biotechnology, Inc.

TCMDTactile Systems Technology Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PBYI

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±45.0%▲+9.73%×0.22

May 8 '26±42.0%▲+3.17%×0.08

Q1 FY26±21.7%▼−25.00%×1.15

Q3 FY25±18.4%▲+22.24%×1.21

TCMD

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.5%▼−17.12%×1.18

Q1 FY26±16.1%▲+7.22%×0.45

= impliedPBYI realized, solidTCMD realized, hatchedOne scale, both sides: full bar = 46%× = |realized| ÷ impliedSource: market data

Feb 18 '26

±19.1%

▲+17.83%

×0.93

Q3 FY25±11.7%▲+40.65%×3.47

PBYIPuma Biotechnology, Inc.

10.42▼−1.09%· post 10.43

Mkt cap$538.9MRevenue$57MQ2 FY26Revenue$228MFY25

TCMDTactile Systems Technology Inc

23.03▼−5.28%· post 23.03

ClosedOct 30 '26

Mkt cap$521.9MRevenue$86MQ2 FY26Revenue$330MFY25

Compare

ClosedOct 30 '26

PBYIPuma Biotechnology, Inc.

TCMDTactile Systems Technology Inc

10.42▼−1.09%post 10.43

Price

23.03▼−5.28%post 23.03

$538.9M

Mkt cap

$521.9M

Q2 FY26$57M

Revenue

$86MQ2 FY26

FY25$228M

Revenue

$330MFY25

PBYI10.42▼−1.09%vsTCMD23.03▼−5.28%ClosedOct 30 '26